[Skip to Navigation]
Sign In

February 2023 - January 1908

Decade

Year

Issue

August 12/26, 2013, Vol 173, No. 15, Pages 1389-1477

In This Issue of JAMA Internal Medicine

Highlights

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1389-1391. doi:10.1001/jamainternmed.2013.6308
Viewpoint

Security, Insecurity, and Health Workers: The Case of Polio

Abstract Full Text
JAMA Intern Med. 2013;173(15):1393-1394. doi:10.1001/jamainternmed.2013.7191

Public Health Responses to Arsenic in Rice and Other Foods

Abstract Full Text
JAMA Intern Med. 2013;173(15):1395-1396. doi:10.1001/jamainternmed.2013.6405
Original Investigation

Rapid Bacterial Whole-Genome Sequencing to Enhance Diagnostic and Public Health Microbiology

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1397-1404. doi:10.1001/jamainternmed.2013.7734

Reuter and colleagues describe an improved genetic technique to confirm or refute outbreaks in hospitals and the community, and the research is further elucidated in the accompanying Article .

Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis: A Randomized Trial

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1407-1414. doi:10.1001/jamainternmed.2013.7801

Eriksson et al investigated whether radiological superiority translates into better work loss outcomes in the treatment of rheumatoid arthritis with biological tumor necrosis factor inhibitors compared with conventional treatment. See the Invited Commentary by Yelin.

Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions: Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1416-1428. doi:10.1001/jamainternmed.2013.7430

After evaluating the full reports of 10 759 articles and abstracts, Maneiro and colleagues analyzed the data from 60 published articles to summarize the influence of antibodies against biologic agents on efficacy and safety in immune-mediated inflammatory diseases.

Long-Term Effects on Cognitive Function of Postmenopausal Hormone Therapy Prescribed to Women Aged 50 to 55 Years

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1429-1436. doi:10.1001/jamainternmed.2013.7727

Espeland et al test whether prescribing conjugated equine estrogen–based hormone therapy to postmenopausal women aged 50 to 55 years has longer-term effects on cognitive function.

Health Care Reform

Correlates of Repeat Lipid Testing in Patients With Coronary Heart Disease

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1439-1444. doi:10.1001/jamainternmed.2013.8198

To determine the frequency and correlates of repeat lipid testing in 35 191 VA patients with CHD who attained LDL-C goals and received no treatment intensification, Virani et al performed logistic regression analyses to evaluate facility, provider, and patient characteristics associated with repeat testing. See the Article by Drozda and the Editor’s Note by Covinsky.

Invited Commentary

The Time Is Now for Gene- and Genome-Based Bacterial Diagnostics: “You Say You Want a Revolution”

Abstract Full Text
JAMA Intern Med. 2013;173(15):1405-1406. doi:10.1001/jamainternmed.2013.7042

Not Better but Quite Good: Effects on Work Loss of Combination Treatment for Rheumatoid Arthritis With and Without Biological Agents

Abstract Full Text
JAMA Intern Med. 2013;173(15):1414-1415. doi:10.1001/jamainternmed.2013.7812

Hormone Therapy in Younger Women and Cognitive Health

Abstract Full Text
JAMA Intern Med. 2013;173(15):1437-1438. doi:10.1001/jamainternmed.2013.6827

Physician Performance Measurement: The Importance of Understanding Physician Behavior

Abstract Full Text
JAMA Intern Med. 2013;173(15):1444-1446. doi:10.1001/jamainternmed.2013.6808

Promoting Delivery System Integration to Foster Higher Value Care: Slow Progress Ahead

Abstract Full Text
JAMA Intern Med. 2013;173(15):1456-1457. doi:10.1001/jamainternmed.2013.7949

Low “T” as in “Template”: How to Sell Disease

Abstract Full Text
JAMA Intern Med. 2013;173(15):1460-1462. doi:10.1001/jamainternmed.2013.7579
Editor's Note

The Problem of Overuse

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1446. doi:10.1001/jamainternmed.2013.8421

Symptom Number and Severity as a Sign of Emotional Distress in Patients With Cardiovascular Disease

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1471. doi:10.1001/jamainternmed.2013.6630
Special Communication

Health Care Reform

Delivery System Integration and Health Care Spending and Quality for Medicare Beneficiaries

Abstract Full Text
JAMA Intern Med. 2013;173(15):1447-1456. doi:10.1001/jamainternmed.2013.6886

McWilliams and colleagues evaluate delivery system integration and health care spending and quality for Medicare beneficiaries, and the analysis is further elucidated in an accompanying Article .

Promoting “Low T”: A Medical Writer’s Perspective

Abstract Full Text
JAMA Intern Med. 2013;173(15):1458-1460. doi:10.1001/jamainternmed.2013.6892

Braun describes how low testosterone level has been marketed to consumers as a disease state in order to boost sales of testosterone replacement therapies.

Evidence to Practice

Nonsurgical Treatments for Urinary Incontinence in Women: Summary of Primary Findings and Conclusions

Abstract Full Text
JAMA Intern Med. 2013;173(15):1463-1464. doi:10.1001/jamainternmed.2013.7818
Research Letter

Trends in Androgen Prescribing in the United States, 2001 to 2011

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1465-1466. doi:10.1001/jamainternmed.2013.6895

ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1466-1468. doi:10.1001/jamainternmed.2013.6638

The Effect of Treatment History on Therapeutic Outcome: An Experimental Approach

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1468-1469. doi:10.1001/jamainternmed.2013.6705

Somatic Symptoms in Patients With Coronary Heart Disease: Prevalence, Risk Factors, and Quality of Life

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1469-1471. doi:10.1001/jamainternmed.2013.6835
Comment & Response

Perceptions of Safety Are Shaped by the Hospital Environment

Abstract Full Text
JAMA Intern Med. 2013;173(15):1471-1472. doi:10.1001/jamainternmed.2013.7741

Perceptions of Safety Are Shaped by the Hospital Environment—Reply

Abstract Full Text
JAMA Intern Med. 2013;173(15):1472-1473. doi:10.1001/jamainternmed.2013.7700

Why Physicians Favored Lipitor Over Simvastatin—Reply

Abstract Full Text
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7701

Why Physicians Favored Lipitor Over Simvastatin

Abstract Full Text
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7747

The Case for Generic Statins: Not If They Don’t Work So Well

Abstract Full Text
JAMA Intern Med. 2013;173(15):1473-1474. doi:10.1001/jamainternmed.2013.7798

The Case for Generic Statins: Not If They Don’t Work So Well—Reply

Abstract Full Text
JAMA Intern Med. 2013;173(15):1474. doi:10.1001/jamainternmed.2013.7781

Does Managed Problem Solving Work and in What Setting?

Abstract Full Text
JAMA Intern Med. 2013;173(15):1474. doi:10.1001/jamainternmed.2013.7788

Does Managed Problem Solving Work and in What Setting?—Reply

Abstract Full Text
JAMA Intern Med. 2013;173(15):1475-1476. doi:10.1001/jamainternmed.2013.7782

Is 81-mg Aspirin Associated With Age-Related Macular Degeneration Risk?—Reply

Abstract Full Text
JAMA Intern Med. 2013;173(15):1476-1477. doi:10.1001/jamainternmed.2013.8131

Is 81-mg Aspirin Associated With Age-Related Macular Degeneration Risk?

Abstract Full Text
JAMA Intern Med. 2013;173(15):1476. doi:10.1001/jamainternmed.2013.8147
Correction

Additional Contributions

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1477. doi:10.1001/jamainternmed.2013.10000

Error in Table

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1477. doi:10.1001/jamainternmed.2013.10002

Errors in Percentages

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1477. doi:10.1001/jamainternmed.2013.9183

Errors in 2 Tables

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1477. doi:10.1001/jamainternmed.2013.9939
JAMA Internal Medicine Masthead

JAMA Internal Medicine

Abstract Full Text
free access
JAMA Intern Med. 2013;173(15):1392-1393. doi:10.1001/jamainternmed.2013.6306
×